Valaciclovir (short‐term) vs placebo
Viral load (shedding) in saliva · participants with recurrent herpes labialis
Valaciclovir (short‐term) showed no clear difference in viral load (shedding) in saliva compared with placebo (moderate certainty).
1 finding from 1 review
- Interventions for prevention of herpes simplex labialis (cold sores on the lips) 2015 · Cochrane Headline outcomes onlyRR 0.16 [0.02, 1.26]1 study · 120 participantsModerate